Abstract
In patients with Alzheimer’s disease (AD), large numbers of senile plaques are found throughout the neuropil of the cerebral neocortex and hippocampus. These senile plaques, which are present in small numbers in the brains of aged mammals and normal elderly individuals, are observed in large numbers only in AD and thus represent a change that is quite specific for this disorder. “Classic” senile plaques consist of a spherical cluster of abnormal neurites surrounding an extracellular amyloid core composed of 5–10 nm fibrils that can be visualized on light microscopy by staining with Congo Red or Thioflavin S (Terry 1985). In most cases of AD, amyloid fibrils are also found in the walls of cerebral vessels (Glenner 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henshen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer’s A4/beta amyloid peptides analogs. J Biol Chem 267 : 546–554
Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid ² protein from a mutant amyloid ² protein precursor. Science 259 : 514–516
Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hugues D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early onset Alzheimer’s disease caused by mutation at codon 71 of the ²-amyloid precursor gene. Nature 353 : 844–846
Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutations of the ² amyloid precursor protein in familial Alzheimer’s disease increase ² protein production. Nature 360 : 672–674
De Sauvage F, Octave J-N (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science 245 : 651–653
Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, Beyreuther K (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s disease. EMBO J 7: 949–957
Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu XM, Tabira T, Greenberg BD, Younkin S (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255 : 726–728
Glenner GG (1983) Alzheimer’s disease: multiple cerebral amyloidosis. In: Katzman R (ed) Banbury Report 15: Biological aspects of Alzheimer’s disease. Cold Spring Harbor Laboratory, New York, pp 137–144
Glenner GG, Wong CW (1984) Alzheimer’s Disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril tangles. Biochem Biophys Res Commun 122 : 1131–1135
Goate AM, Haynes AR, Owen MJ, Farrall M, James LA, Lai LY, Mullan MJ, Roques P, Rossor MN, Williamson R, Hardy JA (1989) Predisposing locus for Alzheimer’s disease on chromosome 21. Lancet 1:352–355
Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 34 : 704–706
Golde TE, Estus SG, Usiak M, Younkin LH, Younkin SG (1990) Expression of β Amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4 : 253–267
Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255 : 728–730
Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235 : 877–880
Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid β peptide is produced by cultured cells during normal metabolism. Nature 359 : 322–325
Hardy J, Mullan M, Chartier-Harlin M-C, Brown J, Goate A, Rossor M, Collinge J, Roberts G, Luthert P, Lantos P, Naruse S, Kaneko K, Tsuji S, Miyatake T, Shimizu T, Kojima T, Nakano I, Yoshioka K, Sakaki Y, Miki T, Katsuya T, Ogihara T, Roses A, Pericak-Vance M, Haan J, Roos R, Lucotte G, David F (1991) Molecular classification of Alzheimer’s disease. Lancet 337:1342–1343
Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K (1991) Aggregation and secondary structure of synthetic amyloid ² A4 peptides of Alzheimer’s disease. J Mol Biol 218 : 149–163
Jacobsen JS, Muerkel HA, Blume AJ, Vitek MP (1991) A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs. Neurobiol Aging 12 : 575–583
Kang, J, LeMaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 : 733–736
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331 : 530–532
Mann DMA, Yates PO, Marcyniuk B, Ravindra CR (1986) The topography of plaques and tangles in Down’s Syndrome patients of different ages. Neuropath Appl Neurobiol 12 : 447–457
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82 : 4245–4249
Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid β protein in Alzheimer’s disease. J Biol Chem 267 : 17082–17086
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfeld L (1992a) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of ²-amyloid. Nature Genet 1: 345–347
Mullan M, Houlden H, Windelspelcht M, Fidani L, Lombardi C, Diaz P, Rossor M, Crook R, Hardy J, Duff K, Crawford F (1992b) A locus for familial early-onset Alzheimer’s disease on the long arm of chromosome 14, proximal to the αl-antichymotrypsin gene. Nature Genet 2:340–342
Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254 : 97–99
Naruse S, Igarashi S, Kobayashi H, Aoki K, Inuzuka T, Kaneko K, Shimizu T, Iihara K, Kojima T, Miyatake T, Tsuji S (1991) Mis-sense mutation Val → Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer’s disease (letter) Lancet 337 : 978–979
Pericak-Vance MA, Yamakoa LH, Haynes CS, Speer MC, Haines JL, Gaskell PC, Hung WY, Clark CM, Heyman AL, Trofatter JA, Eisenmenger JP, Gilbert JR, Lee JE, Alberts MJ, Dawson DV, Bartlett RJ, Earl NL, Siddique T, Vance JM, Conneally PM, Roses AD (1988) Genetic linkage studies in Alzheimer’s disease families. Expl Neurol 102 : 271–279
Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamakoa LH, Hung WY, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA (1991) Linkage studies in familial Alzheimer’s disease: evidence for chromosome 19 linkage. Am J Human Genet 48 : 1034–1050
Ponte G, Gonzales-De Whitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331: 525–527
Prelli F, Castano E, Glenner GG, Frangione BJ (1988) Differences between vascular and plaque core amyloid in Alzheimer’s Disease. Neurochemistry 51 : 648–651
Robakis NK, Wisniewski HM, Jenkins EC, Devine-Gage EA, Houck GE, Yao XL, Ramakrishna N, Wolfe G, Silverman WP, Brown WT (1987) Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet 1: 384–385
Ropper AH, Williams RS (1980) Relationship between plaques, tangles and dementia in Down syndrome. Neurology 30 : 639–644
Schellenberg GD, Bird TD, Wijsman EM, Moore DK, Boehnke M, Bryant EM, Lampe TH, Nochlin D, Sumi SM, Deeb SS, Beyreuther K, Martin GM (1988) Absence of linkage of chromosome 21q21 markers to familial Alzheimer’s disease. Science 241 : 1507–1510
Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME (1992) Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 258: 668–671
Selkoe DJ, Abraham CR, Podlisny MB, Duffy LK (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer’s disease. J Neurochem 46:1820–1834
Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack, R, Wolfert R, Selkoe D, Liebenburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer’s ² peptide from biological fluids. Nature 359 : 325–327
Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B, Younkin SG (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258 : 126–129
St George-Hyslop PH, Haines JL, Farrer LA, Polinsky R, van Broeckhoven C, Goate A, Crapper McLachlan DR, Orr H, Bruni AC, Sorbi S, Rainero I, Foncin J-F, Pollen D, Cantu JM, Tupler R, Voskersenskaya N, Mayeux R, Growdon J, Fried VA, Myers RH, Nee L, Backhoven H, Martin JJ, Rossor M, Owen MJ, Mullan M, Percy ME, Karlinski H, Rich S, Heston L, Montesi M, Mortilla M, Nacmias N, Gusella JF, Hardy JA (1990) Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. Nature 347 : 194–197
St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, Foncin J-F, Montesi M, Bruni A, Sorbi S, Rainero I, Pinessi L, Pollen D, Polinski R, Nee L, Kennedy J, Macciardi F, Rogaeva E, Liang Y, Alexandrova N, Lukiw W, Schlumpf K, Tanzi R, Tsuda T, Farrer L, Cantu J-M, Duara R, Amaducci L, Bergamini L, Gusella J, Roses A, Crapper McLachlan D (1992) Genetic evidence for a novel familial Alzheimer’s disease locus on chromosome 14. Nature Genet 2 : 330–334
Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurmit DN, Neve RI (1987) Amyloid β-protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235 : 880–884
Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 331 : 528–530
Terry RD (1985) Alzheimer’s disease. In: Davis RL, Robertson DM (eds) Textbook of neuropathology. Williams & Wilkins, Baltimore, pp 824–841
Van Broeckhoven C, Backhovens H, Cruts M, De Winter G, Bruyland, Cras P, Martin J-J (1992) Mapping a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3. Nature Genet 2: 335–339
Yoshioka K, Miki T, Katsuya T, Ogihara T, Sakaki Y (1991) The 717Val substitution in amyloid precursor protein is associated with familial Alzheimer’s disease regardless of ethnic groups. Biochem Biophys Res Commun 178 : 1141–1146
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Golde, T.E., Cai, XD., Cheung, TT., Shoji, M., Younkin, S.G. (1994). Production of Amyloid β Protein from Normal and Mutated Amyloid β Protein Precursors. In: Masters, C.L., Beyreuther, K., Trillet, M., Christen, Y. (eds) Amyloid Protein Precursor in Development, Aging and Alzheimer’s Disease. Research and Perspectives in Alzheimer’s Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-01135-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-01135-5_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-01137-9
Online ISBN: 978-3-662-01135-5
eBook Packages: Springer Book Archive